29 June 2022
In the UK, 850,000 people suffer from dementia, with the number set to rise to 2 million by 2051. Dementia currently costs over £600 million a year worldwide. New technology may lead to unprecedented changes in brain development.
Alzheimer’s disease treatment in the 21st Century
The human brain’s ability to adapt to the environment is far above any other species, allowing itself to personalise through neuronal connections to create a unique mind.
During her Public Evening Lecture, Baroness Greenfield will discuss how the introduction of 21st Century technology may lead to unprecedented changes in the development of our brains.
Baroness Greenfield will also address how new imaging methods can visualise fundamental brain mechanisms, as well as new ways of treating Alzheimer’s disease.
Baroness Greenfield, Founder and CEO of Neuro-Bio Ltd (www.neuro-bio. com) is a neuroscientist, writer and broadcaster.
She has published over 200 papers in peer-reviewed journals, based mainly at Oxford University but has held research fellowships at the College de France Paris, NYU Medical Center New York and Melbourne University.
She holds 32 honorary degrees from UK and foreign universities, has received numerous honours including the Legion d’Honneur from the French Government, an Honorary Fellowship from the Royal College of Physicians, The American Academy of Achievement Golden Plate Award, and The Australian Medical Research Society Medal.
She is also a Fellow of the Royal Society of Edinburgh.
14/15 Belgrave Square
Tel: +44 (0)20 7598 1561
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email firstname.lastname@example.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.